BICLUSTER_ID : DNREG-94
PATHOGENS /2/ : bifidobacterium bifidum,helicobacter pylori
TARGETS /67/ : MGST3, NDUFV1, CSNK1G2, NDUFS8, SDHC, NDUFA8, NDUFB7, NDUFS6, TUBB, RAP2A, PEBP1, MUT, CPT1A, ACSL3, PPIB, GM2A, TK1, NDUFC1, NDUFB10, GPT, NDUFA13, CAD, DLAT, CYB5A, NDUFA9, ACAT1, ME2, HADH, IDH1, LARS2, NDUFA4, GLO1, SLC25A13, HSD17B4, DHCR7, CRAT, NNT, NDUFA5, NDUFB8, GALE, TUBB3, FKBP4, NDUFB5, BLVRA, IVD, TGFB1, RAMP1, UQCRC1, S100A6, APEX1, GAMT, SLC25A4, BCAT2, F2R, NFS1, SLC25A15, SDHB, ATP5D, DHODH, CCND1, CAT, ACADM, PARP1, FADS1, ALDH2, SLC25A5, OAT
Gene SetLeading Edge Genes
MOOTHA HUMAN MITODB 6 2002NNT, CRAT, PCK2, ATP5I, UQCR, NDUFB8, MRPL49, MRPL12, BLVRA, IVD, NDUFS8, SLC25A28, NDUFA8, ATP5O, UQCRC1, MBD3, BCAT2, ATP5J2, MUT, CPT1A, ACSL3, ATP5E, MTCH1, BCKDHA, TK1, MRPL46, ACADVL, NFS1, NDUFC1, GPT, SLC25A15, ATP5C1, DLAT, ATP5D, UCP2, DHODH, ACO2, ACAA2, ACADM, MRPS15, CYB5A, SLC9A6, NFKBIL2, ACAT1, ME2, HADH, ALDH2, SLC25A5, LARS2, OAT, NDUFA4, CS, PRDX3, SLC25A13, TRAP1, IDH2, MRPS35, MRPS14, ENDOG
MOOTHA MITOCHONDRIANNT, CRAT, PCK2, ATP5I, UQCR, NDUFB8, MRPL49, MRPL12, IVD, NDUFS8, SLC25A28, MRPL28, NDUFA8, ATP5O, UQCRC1, SLC25A4, MBD3, BCAT2, ATP5J2, MUT, CPT1A, ATP5E, MTCH1, BCKDHA, MRPL46, ACADVL, NFS1, NDUFC1, SLC25A3, SLC25A15, CAD, ATP5C1, MRPL41, DLAT, ATP5D, UCP2, DHODH, CAT, ACO2, ACADM, ACAA2, MRPS15, TP53, CYB5A, SLC9A6, NFKBIL2, ACAT1, PECI, ME2, HADH, ALDH2, SLC25A5, LARS2, OAT, NDUFA4, CS, DCTN6, PRDX3, SLC25A13, IDH2, MRPS14, MRPS35, ENDOG
REACTOME ELECTRON TRANSPORT CHAINNDUFA13, SDHB, NDUFA5, NDUFB8, NDUFV1, NDUFB5, NDUFS8, SDHC, NDUFA8, UQCRC1, NDUFB7, ETFB, NDUFA9, NDUFS6, NDUFA4, UQCRC2, NDUFB11, NDUFC1, NDUFB10
MOOTHA VOXPHOSNDUFA13, ATP5I, ATP5C1, SDHB, UQCR, ATP5D, NDUFB8, ATP5H, NDUFB5, NDUFS8, CYB5A, SDHC, NDUFA8, UQCRC1, NDUFB7, ATP5O, NDUFA9, NFKBIL2, NDUFS6, MBD3, ATP5J2, NDUFA4, ATP5E, UQCRC2, NDUFC1
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UPKIF20A, ENO3, PCK2, ATP5I, SART1, TAOK3, GIPC1, NDUFB8, VASP, CSNK1G2, GALE, TUBB3, PTPN6, EI24, IVD, HMGB3, NDUFS8, CENPF, DBI, AES, UQCRC1, DPAGT1, MBD3, TUBB, UBE2C, PEBP1, BCAT2, ATP5J2, DHCR24, TM6SF1, KIF22, RPS8, PPIB, SMARCA4, ARHGAP1, PTMA, AP3S2, HMBS, EBP, RTN3, CD97, ATP5D, UCP2, CCNF, SPAG5, RAB1B, NUDT3, H2AFX, HMGB1, TP53, FKBP2, CDC20, PARP1, SMARCD2, KHSRP, TMC6, RALY, PHKA2, H2AFV, HSD17B4, ERH, DHCR7
CORUM RESPIRATORY CHAIN COMPLEX I HOLOENZYME MITOCHONDRIALNDUFB7, NDUFA9, NDUFS6, NDUFA13, NDUFA5, NDUFB8, NDUFV1, NDUFA4, NDUFB5, NDUFS8, NDUFB11, NDUFB10, NDUFC1, NDUFA8
ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UPMAN2B1, SET, FKBP5, CETN2, MGST3, METRN, STRA13, SDF2L1, KLF13, ICT1, NDUFA8, CKS1B, RAP2A, TK1, RNASEH2A, XRCC6BP1, NANS, ROCK2, TSPAN14, ARL2BP, RPP21, LMNA, GNPAT, HPS6, GMNN, RNF26, CCT2, CDC20, PSMD6, MAN1A2, IDH1, PFDN6, PHPT1, SUV39H1, RPA1, HIST2H2BE, IMPAD1, RSRC1, ELOVL6, ZMAT3, TMTC4, NRAS, EPHX1, PEA15, NCBP2, SAV1, BLVRA, RAMP1, THAP11, SMARCC1, APEX1, WRB, PDIA6, BCAT2, DDX46, CDR2, STT3B, ASPM, MAPKAPK3, VAMP5, EIF2A, CKAP4, H2AFX, JARID2, TBC1D16, CCNA2, MAFB, SLC9A6, MSH6, PARP1, ZFP106, PURA, ZMPSTE24, ACLY
BORCZUK MALIGNANT MESOTHELIOMA UPPRPS2, PARVB, PRDX4, CCNB1, NCBP2, FKBP4, SS18, BLVRA, TGFB1, MRPL28, THAP11, DBI, CKS1B, SMARCC1, CDKN2C, UBE2C, ZFP161, CAPN7, PLD3, TK1, MAGED1, F2R, BUB1B, UBE2D1, MAD2L1, CCNF, CCNG1, CCT2, HIPK1, MSH6, UBQLN2, PARP1, FADS1, CCT5, GLO1, TUSC3, H2AFV, RPA1, RCN2
ALCALAY AML BY NPM1 LOCALIZATION DNNNT, SEPT9, ANK1, CCNB1, CCNF, STRA13, ACAA2, MICAL1, CORO2A, CCNA2, POLD1, GSN, ACAT1, CCNB2, TUBG1, GAMT, CDC20, SORL1, CDKN2C, KIF23, HADH, CDC25C, UBE2C, POLE2, TK1, RPA1, IDH2, BIRC5
CAFFAREL RESPONSE TO THC DNSESN1, TMEM109, CCNA2, EBP, DHCR7
NCI FOXM1PATHWAYCCNE1, CCNB2, PLK1, CCNB1, AURKB, CCND1, CENPA, NEK2, CCNA2, CHEK2, BIRC5
SHEPARD BMYB TARGETSFBXO5, TTK, CDC20, CKAP2, KIF23, UCP2, CCNB1, AURKB, TK1, MELK, CDCA3, NDE1, ASPM, BIRC5
CONCANNON APOPTOSIS BY EPOXOMICIN DNESPL1, POLR2L, AURKB, CENPA, STMN1, CCNA2, POLD1, DBI, SORL1, CDC20, ICA1, KIF23, UBE2C, METTL7A, DHCR24, GM2A, H2AFV, MAP2K6, LSM2, BIRC5
TANG SENESCENCE TP53 TARGETS DNKIF4A, FBXO5, RACGAP1, CCNB2, TTK, CDC20, UBE2C, CENPA, NEK2, TK1, CCNA2, BIRC5
LEE LIVER CANCER SURVIVAL DNSET, ATP5C1, UBE2D1, PLP2, CCNB1, NCBP2, CCNA2, CENPF, S100A6, RGS2, YWHAB, TTK, ITPR3, CD164, MSH6, ARHGAP18, VCL, CCT5, RPL31, CTBP2
WILCOX PRESPONSE TO ROGESTERONE UP
LOPEZ MESOTELIOMA SURVIVAL TIME UPKIF4A, MELK, CDC25C, BIRC5
KEGG CITRATE CYCLE TCA CYCLE
KEGG FATTY ACID METABOLISM
HASLINGER B CLL WITH 17P13 DELETION
NCI CENTROSOME MATURATION
MONTERO THYROID CANCER POOR SURVIVAL UPCCNB2, NUSAP1, UBE2C, CENPA, ANLN, PRC1, ASPM, BIRC5
KUMAMOTO RESPONSE TO NUTLIN 3A DN
CHEOK RESPONSE TO MERCAPTOPURINE AND HD MTX DN
WALLACE JAK2 TARGETS UP
REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM
THEILGAARD NEUTROPHIL AT SKIN WOUND DN
IVANOVA HEMATOPOIESIS INTERMEDIATE PROGENITOR
SANA RESPONSE TO IFNG DN
TIEN INTESTINE PROBIOTICS 6HR UP
REACTOME CENTROSOME MATURATION
REACTOME PEROXISOMAL LIPID METABOLISM
CORUM F1F0-ATP SYNTHASE EC 3.6.3.14 MITOCHONDRIAL
BANDRES RESPONSE TO CARMUSTIN WITHOUT MGMT 48HR DN
WONG MITOCHONDRIA GENE MODULE
NCI AURORA A PATHWAY
YAGI AML WITH T 8 21 TRANSLOCATION
REACTOME GLUCOSE REGULATION OF INSULIN SECRETION
HONRADO BREAST CANCER BRCA1 VS BRCA2
PASQUALUCCI LYMPHOMA BY GC STAGE DN
REACTOME CHOLESTEROL BIOSYNTHESIS
REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES
CORUM GCN5-TRRAP HISTONE ACETYLTRANSFERASE COMPLEX
STARK PREFRONTAL CORTEX 22Q11 DELETION DN
IVANOVA HEMATOPOIESIS STEM CELL AND PROGENITOR
PENG LEUCINE DEPRIVATION DN
UDAYAKUMAR MED1 TARGETS UP
HEIDENBLAD AMPLICON 8Q24 UP
PUIFFE INVASION INHIBITED BY ASCITES UP
DAZARD UV RESPONSE CLUSTER G5
REACTOME APCDC20 MEDIATED DEGRADATION OF CYCLIN B
ROSS AML WITH AML1 ETO FUSION
SMITH TERT TARGETS DN
NCI BETA OXIDATION OF DECANOYL COA TO OCTANOYL COA COA
REACTOME INFLUENZA LIFE CYCLE
NCI P38GAMMADELTAPATHWAY
KEGG COLORECTAL CANCER
KEGG PEROXISOME
REACTOME FURTHER PLATELET RELEASATE
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 13
FOURNIER ACINAR DEVELOPMENT EARLY UP
REACTOME INTEGRATION OF ENERGY METABOLISM
REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
REACTOME DIABETES PATHWAYS
PYEON HPV POSITIVE TUMORS DN
MOOTHA FFA OXYDATION
CHEN HOXA5 TARGETS 9HR DN
RAMASWAMY METASTASIS UP
BOYLAN MULTIPLE MYELOMA D CLUSTER DN
NCI RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES
REACTOME REGULATION OF INSULIN SECRETION
WAMUNYOKOLI OVARIAN CANCER LMP UP
NCI CDC42 PATHWAY
DOUGLAS BMI1 TARGETS UP
LIANG HEMATOPOIESIS STEM CELL NUMBER SMALL VS HUGE UP
LY AGING MIDDLE DNCDC20, KIF23, PLK1, UBE2C, CCNB1, CCNF, CENPA, H2AFX, CCNA2, CENPF
KEGG THYROID CANCER
KEGG ALZHEIMERS DISEASE
NCI APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B
REACTOME GENES INVOLVED IN APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS
BIOCARTA AKAP95 PATHWAY
NCI INACTIVATION OF APC C VIA DIRECT INHIBITION OF THE APC C COMPLEX
NUYTTEN NIPP1 TARGETS DN
CORUM TGF-BETA RECEPTOR II-TGF-BETA RECEPTOR I-TGF-BETA3 COMPLEX
MUELLER COMMON TARGETS OF AML FUSIONS UP
BROWNE HCMV INFECTION 16HR DN
CAIRO HEPATOBLASTOMA UP
REACTOME PHOSPHORYLATION OF THE APC
SCHLOSSER SERUM RESPONSE AUGMENTED BY MYC
GRADE COLON CANCER UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION DN
BAELDE DIABETIC NEPHROPATHY UP
KEGG P53 SIGNALING PATHWAY
RHODES UNDIFFERENTIATED CANCERCDC20, KIF23, UBE2C, PRDX4, CCNB1, CENPA, MELK, H2AFX, CCNA2, BIRC5
BHATTACHARYA EMBRYONIC STEM CELL
HUANG DASATINIB RESISTANCE DN
NCI MITOTIC TELOPHASE CYTOKINESIS
NCI PHOSPHORYLATION OF THE APC C
STEIN ESRRA TARGETS
FLOTHO PEDIATRIC ALL THERAPY RESPONSE DN
LOPEZ MBD TARGETS
NCI APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS
NCI LOSS OF PROTEINS REQUIRED FOR INTERPHASE MICROTUBULE ORGANIZATION FROM THE CENTROSOME
REACTOME G2 M TRANSITIONSDCCAG8, CCNB2, TUBG1, CEP70, SSNA1, CDC25C, PLK1, CCNB1, NEK2, PRKACA, NUMA1, CCNA2, NDE1, CENPJ
SASAKI ADULT T CELL LEUKEMIA
REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC
CORUM CTCF-NUCLEOPHOSMIN-PARP-HIS-KPNA-LMNA-TOP COMPLEX
KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS
REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
BIOCARTA MPR PATHWAY
CORUM SEMA6D-PLEXINA1-NRP1 COMPLEX
REACTOME INACTIVATION OF APC VIA DIRECT INHIBITION OF THE APCOMPLEX
XU HGF SIGNALING NOT VIA AKT1 48HR DNKIF20A, MAD2L1, PLK1, CENPF, HIST2H2BE, SCD5
SHEPARD CRUSH AND BURN MUTANT DN
CORUM EMERIN COMPLEX 25
KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION
SESTO RESPONSE TO UV C6
JEON SMAD6 TARGETS DN
PENG GLUTAMINE DEPRIVATION DN
SCIBETTA KDM5B TARGETS DN
REACTOME TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL
NCI FURTHER PLATELET RELEASATE
NCI REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE
APPIERTO RESPONSE TO FENRETINIDE DN
FARMER BREAST CANCER APOCRINE VS BASAL
NCI TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL
XU RESPONSE TO TRETINOIN DN
BILD E2F3 ONCOGENIC SIGNATURE
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 12
OHASHI AURKB TARGETS
MILI PSEUDOPODIA HAPTOTAXIS DN
CORUM RALBP1-CCNB1-AP2A-NUMB-EPN1 COMPLEX
CORUM RC COMPLEX DURING G2/M-PHASE OF CELL CYCLE
BIOCARTA HDAC PATHWAY
PRAMOONJAGO SOX4 TARGETS DN
KEGG PARKINSONS DISEASE
STEIN ESRRA TARGETS DN
SESTO RESPONSE TO UV C7
KEGG HUNTINGTONS DISEASE
REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION
MODY HIPPOCAMPUS PRENATAL
KEGG OOCYTE MEIOSIS
NCI BETA OXIDATION OF OCTANOYL COA TO HEXANOYL COA
NCI APC CDC20 MEDIATED DEGRADATION OF NEK2A
KEGG PROPANOATE METABOLISM
REACTOME APOPTOTIC EXECUTION PHASE
DAIRKEE TERT TARGETS UP
TARTE PLASMA CELL VS B LYMPHOCYTE UP
STEIN ESRRA TARGETS UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP
CORUM NOP56P-ASSOCIATED PRE-RRNA COMPLEX
JAEGER METASTASIS UP
POMEROY MEDULLOBLASTOMA PROGNOSIS DN
NCI LOSS OF NLP FROM MITOTIC CENTROSOMES
LIAO METASTASIS
NCI CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE
CHIANG LIVER CANCER SUBCLASS UNANNOTATED DN
ST MYOCYTE AD PATHWAY
BONOME OVARIAN CANCER POOR SURVIVAL DN
ACEVEDO NORMAL TISSUE ADJACENT TO LIVER TUMOR DN
TOMLINS PROSTATE CANCER UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 16
OUELLET CULTURED OVARIAN CANCER INVASIVE VS LMP UP
NCI FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
NCI ECADHERIN STABILIZATION PATHWAY
NADERI BREAST CANCER PROGNOSIS UP
REACTOME SEMA3A PAK DEPENDENT AXON REPULSION
CORUM OLIGOSACCHARYLTRANSFERASE COMPLEX STT3B VARIANT
CORUM RC COMPLEX DURING S-PHASE OF CELL CYCLE
KEGG PROGESTERONE MEDIATED OOCYTE MATURATION
KORKOLA YOLK SAC TUMOR UP
LINDGREN BLADDER CANCER CLUSTER 1 DN
Color legend
q-value-1-0.2-0.05-0.01-0.001-0.0001
Color
TABLE OF Q-VALUES
bifidobacterium bifidumhelicobacter pylori kx2 mgepGeneSet Name
-0.00015 -0.04525MOOTHA_HUMAN_MITODB_6_2002
-0.00104 -0.05512MOOTHA_MITOCHONDRIA
-0.00015 -0.02468REACTOME_ELECTRON_TRANSPORT_CHAIN
-0.00001 -0.02663MOOTHA_VOXPHOS
-0.00023 -0.01305SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
-0.00001 -0.06632CORUM_RESPIRATORY_CHAIN_COMPLEX_I_HOLOENZYME_MITOCHONDRIAL
-0.00072 -0.06916ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
-0.00139 -0.04124BORCZUK_MALIGNANT_MESOTHELIOMA_UP
-0.00007 -0.02204ALCALAY_AML_BY_NPM1_LOCALIZATION_DN
-0.00190 -0.06081CAFFAREL_RESPONSE_TO_THC_DN
-0.00143 -0.03996NCI_FOXM1PATHWAY
-0.00003 -0.00161SHEPARD_BMYB_TARGETS
-0.00077 -0.03239CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN
-0.00022 -0.04893TANG_SENESCENCE_TP53_TARGETS_DN
-0.00053 -0.06341LEE_LIVER_CANCER_SURVIVAL_DN
-0.00264 -0.05284WILCOX_PRESPONSE_TO_ROGESTERONE_UP
-0.00051 -0.03218LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP
-0.00004 -0.10206KEGG_CITRATE_CYCLE_TCA_CYCLE
-0.15893 -0.00028KEGG_FATTY_ACID_METABOLISM
-0.07820 -0.13670HASLINGER_B_CLL_WITH_17P13_DELETION
-0.08432 -0.11324NCI_CENTROSOME_MATURATION
-0.00022 -0.07595MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
-0.02902 -0.08113KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN
-0.00153 -0.18492CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN
-0.00119 -0.08630WALLACE_JAK2_TARGETS_UP
-0.16333 -0.02118REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM
-0.00726 -0.02112THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
-0.00031 -0.14035IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
-0.02951 -0.15550SANA_RESPONSE_TO_IFNG_DN
-0.14622 -0.19575TIEN_INTESTINE_PROBIOTICS_6HR_UP
-0.04334 -0.04721REACTOME_CENTROSOME_MATURATION
-0.10805 -0.04723REACTOME_PEROXISOMAL_LIPID_METABOLISM
-0.00390 -0.01359CORUM_F1F0-ATP_SYNTHASE_EC_3.6.3.14_MITOCHONDRIAL
-0.08134 -0.04522BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN
-0.00930 -0.10879WONG_MITOCHONDRIA_GENE_MODULE
-0.07176 -0.17913NCI_AURORA_A_PATHWAY
-0.10731 -0.10798YAGI_AML_WITH_T_8_21_TRANSLOCATION
-0.00038 -0.10197REACTOME_GLUCOSE_REGULATION_OF_INSULIN_SECRETION
-0.00791 -0.10610HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
-0.00227 -0.04512PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
-0.06933 -0.00656REACTOME_CHOLESTEROL_BIOSYNTHESIS
-0.12803 -0.05496REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
-0.01881 -0.18790CORUM_GCN5-TRRAP_HISTONE_ACETYLTRANSFERASE_COMPLEX
-0.00785 -0.05369STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
-0.11825 -0.09238IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR
-0.00823 -0.03129PENG_LEUCINE_DEPRIVATION_DN
-0.00182 -0.08936UDAYAKUMAR_MED1_TARGETS_UP
-0.01496 -0.06757HEIDENBLAD_AMPLICON_8Q24_UP
-0.05731 -0.17608PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
-0.12038 -0.08615DAZARD_UV_RESPONSE_CLUSTER_G5
-0.02318 -0.06321REACTOME_APCDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
-0.10160 -0.03881ROSS_AML_WITH_AML1_ETO_FUSION
-0.11777 -0.01105SMITH_TERT_TARGETS_DN
-0.18106 -0.13997NCI_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA
-0.02512 -0.03318REACTOME_INFLUENZA_LIFE_CYCLE
-0.00526 -0.09845NCI_P38GAMMADELTAPATHWAY
-0.06566 -0.18287KEGG_COLORECTAL_CANCER
-0.17256 -0.02087KEGG_PEROXISOME
-0.14855 -0.05471REACTOME_FURTHER_PLATELET_RELEASATE
-0.01617 -0.00628YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
-0.12068 -0.11714FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP
-0.02481 -0.05383REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
-0.05646 -0.18269REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC
-0.07164 -0.00913REACTOME_DIABETES_PATHWAYS
-0.13950 -0.12983PYEON_HPV_POSITIVE_TUMORS_DN
-0.09164 -0.00048MOOTHA_FFA_OXYDATION
-0.02064 -0.00090CHEN_HOXA5_TARGETS_9HR_DN
-0.01728 -0.07869RAMASWAMY_METASTASIS_UP
-0.03282 -0.01038BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN
-0.05676 -0.13285NCI_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
-0.01366 -0.03508REACTOME_REGULATION_OF_INSULIN_SECRETION
-0.07811 -0.05255WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
-0.19540 -0.16753NCI_CDC42_PATHWAY
-0.07443 -0.10240DOUGLAS_BMI1_TARGETS_UP
-0.18165 -0.08396LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP
-0.00146 -0.03223LY_AGING_MIDDLE_DN
-0.05291 -0.07627KEGG_THYROID_CANCER
-0.19680 -0.00891KEGG_ALZHEIMERS_DISEASE
-0.04372 -0.06563NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
-0.07686 -0.05951REACTOME_GENES_INVOLVED_IN_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS
-0.13191 -0.08874BIOCARTA_AKAP95_PATHWAY
-0.02067 -0.10034NCI_INACTIVATION_OF_APC_C_VIA_DIRECT_INHIBITION_OF_THE_APC_C_COMPLEX
-0.03076 -0.02846NUYTTEN_NIPP1_TARGETS_DN
-0.14916 -0.15207CORUM_TGF-BETA_RECEPTOR_II-TGF-BETA_RECEPTOR_I-TGF-BETA3_COMPLEX
-0.00718 -0.07828MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP
-0.14798 -0.11575BROWNE_HCMV_INFECTION_16HR_DN
-0.01014 -0.01330CAIRO_HEPATOBLASTOMA_UP
-0.02560 -0.06448REACTOME_PHOSPHORYLATION_OF_THE_APC
-0.14029 -0.08425SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
-0.00153 -0.12859GRADE_COLON_CANCER_UP
-0.00373 -0.00144DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
-0.10341 -0.03987BAELDE_DIABETIC_NEPHROPATHY_UP
-0.11834 -0.16316KEGG_P53_SIGNALING_PATHWAY
-0.00003 -0.05496RHODES_UNDIFFERENTIATED_CANCER
-0.05096 -0.12498BHATTACHARYA_EMBRYONIC_STEM_CELL
-0.11785 -0.10598HUANG_DASATINIB_RESISTANCE_DN
-0.03173 -0.16617NCI_MITOTIC_TELOPHASE__CYTOKINESIS
-0.02484 -0.06727NCI_PHOSPHORYLATION_OF_THE_APC_C
-0.00423 -0.01868STEIN_ESRRA_TARGETS
-0.06470 -0.00309FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN
-0.01923 -0.12405LOPEZ_MBD_TARGETS
-0.04166 -0.07750NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
-0.08367 -0.10588NCI_LOSS_OF_PROTEINS_REQUIRED_FOR_INTERPHASE_MICROTUBULE_ORGANIZATION_FROM_THE_CENTROSOME
-0.00061 -0.04505REACTOME_G2_M_TRANSITION
-0.02669 -0.04079SASAKI_ADULT_T_CELL_LEUKEMIA
-0.07170 -0.16967REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC
-0.11832 -0.06310CORUM_CTCF-NUCLEOPHOSMIN-PARP-HIS-KPNA-LMNA-TOP_COMPLEX
-0.06641 -0.06271KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS
-0.00556 -0.00605REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
-0.10153 -0.00166BIOCARTA_MPR_PATHWAY
-0.10344 -0.14211CORUM_SEMA6D-PLEXINA1-NRP1_COMPLEX
-0.02271 -0.09045REACTOME_INACTIVATION_OF_APC_VIA_DIRECT_INHIBITION_OF_THE_APCOMPLEX
-0.00001 -0.07933XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN
-0.00019 -0.18475SHEPARD_CRUSH_AND_BURN_MUTANT_DN
-0.16297 -0.08431CORUM_EMERIN_COMPLEX_25
-0.01075 -0.00209KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
-0.00481 -0.11512SESTO_RESPONSE_TO_UV_C6
-0.00006 -0.11485JEON_SMAD6_TARGETS_DN
-0.00144 -0.16100PENG_GLUTAMINE_DEPRIVATION_DN
-0.00001 -0.12404SCIBETTA_KDM5B_TARGETS_DN
-0.00352 -0.08274REACTOME_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL
-0.13123 -0.06772NCI_FURTHER_PLATELET_RELEASATE
-0.00242 -0.06693NCI_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE
-0.07237 -0.15706APPIERTO_RESPONSE_TO_FENRETINIDE_DN
-0.15911 -0.05512FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
-0.00385 -0.08620NCI_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL
-0.11006 -0.12397XU_RESPONSE_TO_TRETINOIN_DN
-0.07288 -0.07163BILD_E2F3_ONCOGENIC_SIGNATURE
-0.05594 -0.00021YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
-0.01367 -0.07556OHASHI_AURKB_TARGETS
-0.10293 -0.19233MILI_PSEUDOPODIA_HAPTOTAXIS_DN
-0.07731 -0.04673CORUM_RALBP1-CCNB1-AP2A-NUMB-EPN1_COMPLEX
-0.00028 -0.05125CORUM_RC_COMPLEX_DURING_G2/M-PHASE_OF_CELL_CYCLE
-0.08186 -0.06298BIOCARTA_HDAC_PATHWAY
-0.00435 -0.00274PRAMOONJAGO_SOX4_TARGETS_DN
-0.01713 -0.01552KEGG_PARKINSONS_DISEASE
-0.12405 -0.00968STEIN_ESRRA_TARGETS_DN
-0.00440 -0.10047SESTO_RESPONSE_TO_UV_C7
-0.00740 -0.08702KEGG_HUNTINGTONS_DISEASE
-0.05342 -0.03505REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION
-0.01217 -0.00629MODY_HIPPOCAMPUS_PRENATAL
-0.00459 -0.01189KEGG_OOCYTE_MEIOSIS
-0.17278 -0.13483NCI_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA
-0.01357 -0.05605NCI_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
-0.09374 -0.07154KEGG_PROPANOATE_METABOLISM
-0.08500 -0.13410REACTOME_APOPTOTIC_EXECUTION_PHASE
-0.06198 -0.08492DAIRKEE_TERT_TARGETS_UP
-0.07638 -0.18262TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
-0.00248 -0.02890STEIN_ESRRA_TARGETS_UP
-0.02139 -0.08659RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
-0.03158 -0.04069CORUM_NOP56P-ASSOCIATED_PRE-RRNA_COMPLEX
-0.06706 -0.18462JAEGER_METASTASIS_UP
-0.02061 -0.07322POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
-0.08105 -0.10130NCI_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
-0.06913 -0.14125LIAO_METASTASIS
-0.09131 -0.16063NCI_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE
-0.00019 -0.11953CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
-0.12742 -0.19908ST_MYOCYTE_AD_PATHWAY
-0.02551 -0.13399BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN
-0.12411 -0.08393ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
-0.01698 -0.16415TOMLINS_PROSTATE_CANCER_UP
-0.17636 -0.05947YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16
-0.15117 -0.09820OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
-0.00693 -0.00769NCI_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
-0.12174 -0.13858NCI_ECADHERIN_STABILIZATION_PATHWAY
-0.00016 -0.19898NADERI_BREAST_CANCER_PROGNOSIS_UP
-0.16481 -0.01097REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION
-0.15048 -0.15875CORUM_OLIGOSACCHARYLTRANSFERASE_COMPLEX_STT3B_VARIANT
-0.00007 -0.17471CORUM_RC_COMPLEX_DURING_S-PHASE_OF_CELL_CYCLE
-0.02276 -0.14118KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
-0.09986 -0.09261KORKOLA_YOLK_SAC_TUMOR_UP
-0.00138 -0.13629LINDGREN_BLADDER_CANCER_CLUSTER_1_DN